Abnormal movements and rigidity induced by harmaline in relation to striatal acetylcholine, serotonin, and dopamine.
D006916:5-Hydroxytryptophan; D000109:Acetylcholine / Q000378:metabolism; D000470:Alkaloids / Q000008:administration & dosage*; D000818:Animals; D001479:Basal Ganglia / Q000032:analysis / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002421:Caudate Nucleus / Q000032:analysis / Q000187:drug effects; D002713:Chlorine; D004298:Dopamine / Q000378:metabolism; D006651:Histocytochemistry; D007211:Indoles / Q000008:administration & dosage*; D008694:Methamphetamine; D008854:Microscopy, Electron; D008996:Monoamine Oxidase Inhibitors; D009069:Movement Disorders / Q000139:chemically induced*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013572:Synaptic Vesicles / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced
D000470:Alkaloids; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D008694:Methamphetamine; D002713:Chlorine; D006916:5-Hydroxytryptophan; D000109:Acetylcholine; D004298:Dopamine